Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,037 | 23,044 | 17,136 | 28,356 | 36,399 |
| Marketable Securities | 547,186 | 607,293 | 656,155 | 696,925 | 719,600 |
| Receivables | 90 | 90 | 1,064 | 700 | 852 |
| TOTAL | $604,339 | $648,404 | $693,757 | $747,159 | $778,842 |
| Non-Current Assets | |||||
| PPE Net | 4,829 | 4,392 | 4,601 | 4,346 | 4,230 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 12,081 | 12,421 | 13,923 | 13,645 | 12,917 |
| TOTAL | $44,100 | $44,003 | $45,714 | $45,181 | $44,337 |
| Total Assets | $648,439 | $692,407 | $739,471 | $792,340 | $823,179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,267 | 2,073 | 3,410 | 3,265 | 1,114 |
| Accrued Expenses | 39,715 | 28,424 | 25,456 | 33,842 | 28,204 |
| Other current liabilities | 930 | 930 | 1,653 | 942 | 1,396 |
| TOTAL | $46,465 | $32,963 | $32,018 | $39,501 | $32,093 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,611 | 4,038 | 4,472 | 5,834 | 5,181 |
| TOTAL | $3,611 | $4,038 | $4,472 | $5,834 | $5,181 |
| Total Liabilities | $50,076 | $37,001 | $36,490 | $45,335 | $37,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,449 | 66,407 | 66,394 | 66,384 | 66,344 |
| Common Shares | 66 | 66 | 66 | 66 | 66 |
| Retained earnings | -1,732,664 | -1,665,620 | -1,609,020 | -1,555,224 | -1,508,132 |
| Other shareholders' equity | 3,765 | 3,339 | 3,568 | 3,314 | 5,288 |
| TOTAL | $598,363 | $655,406 | $702,981 | $747,005 | $785,905 |
| Total Liabilities And Equity | $648,439 | $692,407 | $739,471 | $792,340 | $823,179 |